SCHEMBL23369100

SCHEMBL23369100

C[C@H]1C[C@H](c2cnc3c(N)nc(N)nn23)O[C@@H]1COCc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HSPA5 P11021 3/20 0.39
▸ PDE2A O00408 2/20 0.36
▸ CDK1 P06493 1/20 0.34
▸ CCNB1 P14635 1/20 0.34
▸ MGMT P16455 1/20 0.34
▸ CCNA2 P20248 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ CCNA1 P78396 1/20 0.34
▸ TAAR1 Q96RJ0 1/20 0.34
▸ ATG7 O95352 1/20 0.33
▸ HRH4 Q9H3N8 4/20 0.32
▸ HRH3 Q9Y5N1 4/20 0.32
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31
▸ CA9 Q16790 1/20 0.31
▸ ADORA2A P29274 2/20 0.31
▸ ADORA1 P30542 2/20 0.31
▸ AXL P30530 1/20 0.31
▸ MERTK Q12866 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20404119 0.83 PDE2A (0.42) HSPA5PDE2ACDK1CCNB1MGMT
SCHEMBL13648874 0.80 PDE2A (0.44) HSPA5PDE2ACA1CA2CA9
SCHEMBL18787315 0.77 PDE2A (0.52) HSPA5PDE2ACA1CA2CA9
SCHEMBL19292561 0.76 PDE2A (0.35) HSPA5PDE2ACDK1CCNB1MGMT
SCHEMBL12253818 0.76 PDE2A (0.37) HSPA5PDE2ACDK1CCNB1MGMT
SCHEMBL18787325 0.72 PDE2A (0.38) HSPA5PDE2ACDK1CCNB1MGMT
SCHEMBL12836757 0.71 PDE2A (0.38) HSPA5PDE2AATG7
SCHEMBL19292106 0.71 DNMT1 (0.44) ADORA2A
SCHEMBL19859840 0.71 PDE2A (0.42) HSPA5PDE2AATG7CA1CA2
SCHEMBL19292122 0.70 TAAR1 (0.36) HSPA5PDE2ATAAR1ATG7HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3351552-B1 2'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT GILEAD SCIENCES INC (US) 2021-05-19 — — EP disclosed
Send feedback